Exon duplication and divergence in the human preproglucagon gene
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“and while GIP-mediated weight loss is fully preserved in Glp1r-deficient mice45,49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIP-driven weight loss is also synergistically enhanced by adjunct GLP-1R agonism47-49,117.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [49]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Organization and Expression of Eucaryotic Split Genes Coding for Proteins
Breathnach, R., & Chambon, P. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.002025 · Cited by 4,548
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,797
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., & Roe, B. A. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90196-5 · Cited by 3,407
Wahl, G. M., Stern, M., & Stark, G. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.3683 · Cited by 3,247
Gilbert, W. (1978) · Nature · doi:10.1038/271501a0 · Cited by 2,300
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
The structure and evolution of the human β-globin gene family
Efstratiadis, A. (1980) · Cell · doi:10.1016/0092-8674(80)90429-8 · Cited by 1,375
Research works printed but not linked: 2
- Unger, R. H.& Orci, L. (eds) Glucagon, Physiology, Pathophysiology and Morphology of the Pancreatic A-cell (Elsevier, New York, 1981).
- O'Farrell, P. Focus 3 (3), 1–3 (1981).
Cited by
Items 101–200 of 595
DPP-4 Inhibition and the Path to Clinical Proof
Åhrén, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00376 · Cited by 138
Glucagon-like peptide 2 function in domestic animals
Burrin, D. G., Stoll, B., & Guan, X. (2003) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(02)00210-2 · Cited by 146
The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair
Barton, E. R. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-054 · Cited by 126
Transforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
Holst, J. J. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01113-9 · Cited by 125
“Proglucagon is produced in endocrine epithelial L cells of the intestinal mucosa as well as in alpha cells of the pancreatic islets of Langerhans and is encoded by the (pro)glucagon gene 3 .”
Identical mRNA for preproglucagon in pancreas and gut
NOVAK, U., WILKS, A., BUELL, G., & McEWEN, S. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11162.x · Cited by 124
Nauck, M. A., Tuttle, K. R., Tschöp, M. H., & Blüher, M. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02105-1 · Cited by 123
Grieve, D. J., Cassidy, R. S., & Green, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00376.x · Cited by 121
Dietary Fiber in the Prevention and Treatment of Metabolic Syndrome: A Review
Aleixandre, A., & Miguel, M. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701761886 · Cited by 138
Glucagon-like peptide-1 (GLP-1): A gut hormone of potential interest in the treatment of diabetes
Ahrén, B. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199808)20:8<642::aid-bies7>3.0.co;2-k · Cited by 125
Raufman, J. P., Singh, L., Singh, G., & Eng, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36628-1 · Cited by 122
DPP-4 inhibitors in the treatment of type 2 diabetes
Duez, H., Cariou, B., & Staels, B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.028 · Cited by 110
Structure of the human ghicagon gene
White, J. W., & Saunders, G. F. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.12.4719 · Cited by 118
Structure of the Human Vasoactive Intestinal Polypeptide Gene
Tsukada, T., Horovitch, S. J., Montminy, M., Mandel, G., & Goodman, R. H. (1985) · DNA · doi:10.1089/dna.1985.4.293 · Cited by 124
Patzelt, C., & Schiltz, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5007 · Cited by 118
Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor.
Takeda, J., Seino, Y., Tanaka, K., Fukumoto, H., Kayano, T., Takahashi, H., Mitani, T., Kurono, M., Suzuki, T., & Tobe, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7005 · Cited by 115
Böttcher, G., Alumets, J., Håkanson, R., & Sundler, F. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90046-7 · Cited by 114
Siegfried, J. M., Kasprzyk, P. G., Treston, A. M., Mulshine, J. L., Quinn, K., & Cuttitta, F. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8107 · Cited by 112
Human glucagon‐like peptides 1 and 2 activate rat brain adenylate cyclase
Hoosein, N. M., & Gurd, R. S. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81245-4 · Cited by 113
Green, B., Gault, V., O'Harte, F., & Flatt, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382774 · Cited by 111
The Incretin Approach for Diabetes Treatment
Holst, J. J., & Ørskov, C. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s197 · Cited by 106
Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo
Kato, Y., Yu, D., & Schwartz, M. Z. (1999) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(99)90221-x · Cited by 126
Nagell, C. F., Wettergren, A., Pedersen, J. F., Mortensen, D., & Holst, J. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004424 · Cited by 108
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
Larsen, P. J., & Holst, J. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.026 · Cited by 125
Briyal, S., Shah, S. Z., & Gulati, A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.064 · Cited by 109
Zarrinpar, A., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 103
Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors
Holst, J. J. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.9.1.155 · Cited by 103
GLP-1 based therapy for type 2 diabetes
Arulmozhi, D. K., & Portha, B. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.003 · Cited by 113
The Origin and Understanding of the Incretin Concept
Rehfeld, J. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00387 · Cited by 102
Sørensen, L. B., Flint, A., Raben, A., Hartmann, B., Holst, J. J., & Astrup, A. V. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802247 · Cited by 107
Drucker, D. J., Mojsov, S., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67561-1 · Cited by 103
Is glucagon-like peptide 1 an incretin hormone?
Nauck, M. A. (1999) · Diabetologia · doi:10.1007/s001250051165 · Cited by 112
The glucagon superfamily: Precursor structure and gene organization
Bell, G. I. (1986) · Peptides · doi:10.1016/0196-9781(86)90160-9 · Cited by 118
Self-citationGlucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 112
Drucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7386 · Cited by 97
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 110
Mechanisms of intestinal adaptation
Bristol, J. B., & Williamson, R. C. N. (1988) · Pediatric Surgery International · doi:10.1007/bf00179248 · Cited by 97
Incretins and the development of type 2 diabetes
Meier, J. J., & Nauck, M. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0034-7 · Cited by 105
Diet: Friend or Foe of Enteroendocrine Cells: How It Interacts with Enteroendocrine Cells
Morán‐Ramos, S., Tovar, A. R., & Torres, N. (2012) · Advances in Nutrition · doi:10.3945/an.111.000976 · Cited by 111
McRory, J. E., & Sherwood, N. M. (1997) · Endocrinology · doi:10.1210/endo.138.6.5167 · Cited by 95
Knop, F. K. (2009) · Diabetologia · doi:10.1007/s00125-009-1511-8 · Cited by 102
Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective
Nauck, M. A. (1998) · Acta Diabetologica · doi:10.1007/s005920050116 · Cited by 94
Glucagon-Like Peptide 2: A Nutrient-Responsive Gut Growth Factor
Burrin, D. G., Stoll, B., Petersen, Y. M., & Sangild, P. T. (2001) · Journal of Nutrition · doi:10.1093/jn/131.3.709 · Cited by 94
Katinakis, P. K., & Verma, D. P. S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4157 · Cited by 94
Mechanisms underlying proglucagon gene expression
Jin, T. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0085 · Cited by 91
Exendin-4 Potently Decreases Ghrelin Levels in Fasting Rats
Pérez-Tilve, D., González-Matías, L., Alvarez-Crespo, M., Leiras, R., Tovar, S., Diéguez, C., & Mallo, F. (2007) · Diabetes · doi:10.2337/db05-0996 · Cited by 92
Gastrointestinal peptides and insulin secretion
Ebert, R., & Creutzfeldt, W. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030101 · Cited by 99
Lipolytic action of glucagon-like peptides in isolated rat adipocytes
Ruiz-Grande, C., Alarcón, C., Mérida, E., & Valverde, I. (1992) · Peptides · doi:10.1016/0196-9781(92)90134-o · Cited by 89
Structure and Pancreatic Expression of the Insulin and Glucagon Genes*
Philippé, J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-3-252 · Cited by 89
Glucagon‐like peptide‐1(7–36) amide is a new incretin/enterogastrone candidate
Göke, R., Fehmann, H. C., & Göke, B. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01802.x · Cited by 102
Isolation and structures of coho salmon (Oncorhynchus kisutch) glucagon and glucagon-like peptide
Plisetskaya, E. M., POLLOCK, H. G., Rouse, J. B., Hamilton, J. W., KIMMEL, J. R., & Gorbman, A. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90205-3 · Cited by 89
Ban, K., Hui, S., Drucker, D. J., & Husain, M. (2009) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2009.04.001 · Cited by 88
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive Physiology · doi:10.1002/cphy.c200013 · Cited by 59
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
Willard, F. S., & Sloop, K. W. (2012) · Experimental Diabetes Research · doi:10.1155/2012/470851 · Cited by 79
Rountree, D. B., Ulshen, M. H., Selub, S. E., Fuller, C. R., Bloom, S. R., Ghatei, M. A., & Lund, P. K. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90835-m · Cited by 84
Isolation and structures of glucagon and glucagon-like peptide from catfish pancreas.
Andrews, P., & Ronner, P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89208-0 · Cited by 82
Actions of glucagon‐like peptide‐1 receptor ligands in the gut
Holst, J. J., Andersen, D. B., & Grunddal, K. V. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15611 · Cited by 73
Glucagon gene 5'-flanking sequences promote islet cell-specific gene transcription.
Drucker, D. J., Philippé, J., Jepeal, L. I., & Habener, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47777-0 · Cited by 87
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
Hjørne, A. P., Modvig, I. M., & Holst, J. J. (2022) · Metabolites · doi:10.3390/metabo12050420 · Cited by 71
Martin, G., Beck, P.-L., & Sigalet, D.-L. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i26.4117 · Cited by 85
Structure of vertebrate genes: A statistical analysis implicating selection
Smith, M. W. (1988) · Journal of Molecular Evolution · doi:10.1007/bf02099729 · Cited by 79
Huang, Z., Liu, L., Zhang, J., Conde, K., Phansalkar, J., Li, Z., Yao, L., Xu, Z., Wang, W., Zhou, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5345 · Cited by 78
Ileal glucagon gene expression: Ontogeny and response to massive small bowel resection
Taylor, R. G., Verity, K., & Fuller, P. J. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90961-y · Cited by 83
The Incretin Notion and its Relevance to Diabetes
Habener, J. F. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30135-x · Cited by 89
Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide
Meier, J. J., & Nauck, M. A. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.08.007 · Cited by 82
Ørskov, J. J. H. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.75.85 · Cited by 71
Control of Glucagon-Like Immunoreactive Peptide Secretion from Fetal Rat Intestinal Cultures*
BRUBAKER, P. L. (1988) · Endocrinology · doi:10.1210/endo-123-1-220 · Cited by 89
BRUBAKER, P. L., & VRANIC, M. (1987) · Endocrinology · doi:10.1210/endo-120-5-1976 · Cited by 75
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H.-W., Cerbone, M., & Dattani, M. T. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 65
Proglucagon-Derived Peptides as Therapeutics
Lafferty, R. A., O’Harte, F. P. M., Irwin, N., Gault, V. A., & Flatt, P. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689678 · Cited by 71
Yang, J.-L., Chen, W.-Y., Chen, Y.-P., Kuo, C.-Y., & Chen, S.-D. (2016) · Theranostics · doi:10.7150/thno.15993 · Cited by 74
Renal catabolism of human glucagon-like peptides 1 and 2
Ruiz-Grande, C., Pintado, J., Alarcón, C., Castilla, C., Valverde, I., & López-Novoa, J. M. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-239 · Cited by 72
Tseng, C. C., Jarboe, L. A., Landau, S. B., Williams, E. K., & Wolfe, M. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1992 · Cited by 70
Holst, J. J., Albrechtsen, N. J. W., Rosenkilde, M. M., & Deacon, C. F. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180013 · Cited by 54
Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine.
Buhl, T., Thim, L., Kofod, H., Orskov, C., Harling, H., & Holst, J. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68350-4 · Cited by 72
The incretins: a link between nutrients and well-being
Burcelin, R. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041340 · Cited by 70
Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats
Briyal, S., Gulati, K., & Gulati, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.026 · Cited by 71
Eng, J., Andrews, P. C., Kleinman, W. A., Singh, L., & Raufman, J. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30498-2 · Cited by 68
Fukase, N., Igarashi, M., Takahashi, H., Manaka, H., Yamatani, K., Daimon, M., Tominaga, M., & Sasaki, H. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb01995.x · Cited by 69
Vasoactive Intestinal Polypeptide and Related Peptides. Isolation and Chemistrya
Mutt, V. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb26968.x · Cited by 69
Effect of glucagon-like peptide-1 on insulin secretion
Shima, K., Hirota, M., & Ohboshi, C. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90037-7 · Cited by 79
Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance
Pujadas, G., & Drucker, D. J. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1078 · Cited by 65
Wettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · Peptides · doi:10.1016/s0196-9781(98)00020-5 · Cited by 67
Proteins, exons and molecular evolution
Holland, S., & Blake, C. C. F. (1987) · Biosystems · doi:10.1016/0303-2647(87)90044-x · Cited by 71
Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury
Matheeussen, V., Jungraithmayr, W., & Meester, I. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.012 · Cited by 69
Hunt, J. E., Holst, J. J., Jeppesen, P. B., & Kissow, H. (2021) · Biomedicines · doi:10.3390/biomedicines9040383 · Cited by 65
Expression of the Small Peptide GLP-1 in Transgenic Plants
Yasuda, H., Tada, Y., Hayashi, Y., Jomori, T., & Takaiwa, F. (2005) · Transgenic Research · doi:10.1007/s11248-005-6631-4 · Cited by 65
Obesity treatment: novel peripheral targets
Field, B. C. T., Chaudhri, O. B., & Bloom, S. R. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03522.x · Cited by 64
Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 Receptors
Suzuki, R., Brown, G. A., Christopher, J. A., Scully, C. C. G., & Congreve, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00835 · Cited by 60
Seino, S., Welsh, M., Bell, G. I., Chan, S. J., & Steiner, D. F. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)81429-6 · Cited by 64
Self-citationExenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
Briones, M., & Bajaj, M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1055 · Cited by 63
Molecular forms of glucagon‐like peptides in man
George, S. K., Uttenthal, L. O., Ghiglione, M., & Bloom, S. R. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80124-1 · Cited by 64
Methods and Guidelines for Measurement of Glucagon in Plasma
Holst, J. J., & Albrechtsen, N. J. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215416 · Cited by 62
Immunohistochemical localization of glucagon-like peptide 1
Kauth, T., & Metz, J. (1987) · Histochemistry and Cell Biology · doi:10.1007/bf00500625 · Cited by 61
Tao, X., Cai, L., Chen, L., Ge, S., & Deng, X. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0555-8 · Cited by 58
Philippe, J., Drucker, D. J., & Habener, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75713-5 · Cited by 63
Evolution of the Neuropeptide Y Family of Peptides
Larhammar, D., Söderberg, C., & Blomquist, A. G. (1993) · Humana Press eBooks · doi:10.1007/978-1-59259-465-8_1 · Cited by 60
Hamed, K. M., Alosaimi, M. N., Ali, B. A., Alghamdi, A. M., Alkhashi, T., Alkhaldi, S. S., Altowarqi, N. A., Alzahrani, H., Alshehri, A., Alkhaldi, R. K., et al. (2024) · Cureus · doi:10.7759/cureus.68390 · Cited by 94
Tessari, P., Kiwanuka, E., Cristini, M., Zaramella, M., Enslen, M., Zurlo, C., & Garcia‐Rodenas, C. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.698 · Cited by 55
The role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 63
Metadata
- Authors
- Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C.
- ORCID
- Laybourn, Paul J.
- Venue
- Nature
- Published
- 1983-07
- Volume
- 304
- Issue
- 5924
- Pages
- 368-371
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003141714
- Cited by
- 593
- References
- 36
- Citations by year
- 2026: 16 · 2025: 21 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 10 · 2016: 16 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 13
- FWCI
- 36.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- exon duplication, glucagon, glucagon-like peptide-1, glucagon-like peptide-2, signal peptide, gene structure
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Glucagon, Cricetinae, Humans, Insulin, Proinsulin, Protein Precursors, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.